OpenLegislation

Regulation 81 Amendment of regulation 72 (sale etc of suspended medicinal product)I1F1

United Kingdom

In regulation 72(1), for “regulation 69 or 70(2) or Article 20(4) of Regulation (EC) No 726/2004” substitute—

“—

(a)

in the case of a medicinal product authorised for sale or supply by a UKMA(GB), regulation 69;

(b)

in the case of a medicinal product authorised for sale or supply by a UKMA(NI) or UKMA(UK), regulation 69 or Article 20(4) of Regulation (EC) No 726/2004.”.

Annotations

Textual amendments

F1

Reg. 81 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 59

Commencement

I1

Reg. 81 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1